ONI
Private Company
Total funding raised: $32.5M
Overview
ONI is a private, commercial-stage company providing an integrated hardware and software platform for super-resolution microscopy, targeting the life science research market. Its core offering includes compact, user-friendly benchtop instruments (Nanoimager, Aplo Scope) and flow imaging systems (Aplo Flow) designed to make nanoscale imaging accessible to non-specialist labs. By combining proprietary optics, sample preparation protocols, and AI-powered analysis software, ONI enables researchers to study molecular structures, interactions, and dynamics with unprecedented detail. The company operates on a diagnostics and tools business model, generating revenue from the sale of instruments, reagents, and software subscriptions.
Technology Platform
Integrated super-resolution microscopy platform combining proprietary benchtop hardware (Nanoimager, Aplo Scope, Aplo Flow) for single-molecule localization techniques (dSTORM, PALM, DNA-PAINT) with AI/ML-powered software (CODI) for data acquisition, processing, and quantitative analysis.
Funding History
3Opportunities
Risk Factors
Competitive Landscape
ONI competes with large microscopy incumbents (Zeiss, Leica, Nikon, Olympus) offering super-resolution systems, as well as other specialists in SMLM. Its key differentiation is the compact, integrated benchtop format combined with user-friendly AI software, targeting labs that prioritize accessibility and quantitative analysis over maximum configurability.